Evoxac
Term · Oncology and biomedicine · MLC-T-ONC-003041
A drug used to treat certain disorders of the salivary gland. It is also being studied as a treatment for dry mouth caused by radiation therapy to the head and neck. It increases the amount of saliva and sweat made by saliva and sweat glands. Evoxac is a type of cholinergic agonist. Also called cevimeline hydrochloride.
| Identifier | MLC-T-ONC-003041 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | cevimeline hydrochloride |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-003041",
"term": "Evoxac",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat certain disorders of the salivary gland. It is also being studied as a treatment for dry mouth caused by radiation therapy to the head and neck. It increases the amount of saliva and sweat made by saliva and sweat glands. Evoxac is a type of cholinergic agonist. Also called cevimeline hydrochloride.",
"synonyms": [
"cevimeline hydrochloride"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/evoxac/"
}
Record 7,009 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.